Crossmark

Evaluation of maintenance of the common androgen deprivation therapy with the new antiandrogen therapy in patients with castration-resistant prostate cancer: a systematic review

Crossref DOI link: https://doi.org/10.1007/s11255-022-03201-9

Published Online: 2022-04-06

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Salgado, Carla Manzoni https://orcid.org/0000-0002-2259-9988
Garcia-Perdomo, Herney Andrés

Reis, Leonardo O.
License Information

Text and Data Mining valid from 2022-04-06

Version of Record valid from 2022-04-06
More Information

Article History

Received: 31 January 2022

Accepted: 27 March 2022

First Online: 6 April 2022

Declarations

:

: Author CMS, HGP, and LOR declare that they have no conflict of interest.

: This article does not contain any studies with human participants performed by any of the authors.

Document is current

Any future updates will be listed below